APA citiranje

Jabbour, E., Kantarjian, H. M., Saglio, G., Steegmann, J. L., Shah, N. P., Boqué, C., . . . Hochhaus, A. (2014). Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION). American Society of Hematology.

Citação norma Chicago

Jabbour, Elias, et al. Early Response With Dasatinib or Imatinib in Chronic Myeloid Leukemia: 3-year Follow-up From a Randomized Phase 3 Trial (DASISION). American Society of Hematology, 2014.

MLA citiranje

Jabbour, Elias, et al. Early Response With Dasatinib or Imatinib in Chronic Myeloid Leukemia: 3-year Follow-up From a Randomized Phase 3 Trial (DASISION). American Society of Hematology, 2014.